IQVIA Holdings Inc.
IQV
株式のランク
#561
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical... IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
株価
$266.90
最終同期: 2026-10-16
時価総額
$43.93B
変化（1日）
-1.32%
変化（1年）
30.48%
国
US
取引 IQVIA Holdings Inc. (IQV)
カテゴリー
Healthcare
IQVIA Holdings Inc.（IQV）の営業利益率
October 2026 時点の営業利益率 TTM: 13.57%
IQVIA Holdings Inc. の最新の財務報告と株価によると、現在の営業利益率（TTM）は 13.57% です。2024 年末時点では 14.29% でした。
IQVIA Holdings Inc. の営業利益率の履歴（2010 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 13.57% | -3.21% |
| 2025 | 14.02% | -1.89% |
| 2024 | 14.29% | 8.34% |
| 2023 | 13.19% | 5.69% |
| 2022 | 12.48% | 24.30% |
| 2021 | 10.04% | 55.90% |
| 2020 | 6.44% | -8.13% |
| 2019 | 7.01% | -1.54% |
| 2018 | 7.12% | -3.91% |
| 2017 | 7.41% | -21.34% |
| 2016 | 9.42% | -16.42% |
| 2015 | 11.27% | 4.26% |
| 2014 | 10.81% | 19.18% |
| 2013 | 9.07% | 11.29% |
| 2012 | 8.15% | 2.13% |
| 2011 | 7.98% | -20.75% |
| 2010 | 10.07% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 17.97% | -98.68% |
US
|
|
| 20.42% | -98.50% |
US
|
|
| -10.70% | -100.79% |
US
|
|
| 0.00% | - |
CN
|
|
| 22.23% | -98.36% |
US
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。